Cogent Biosciences, Inc. (COGT)
35.52
-1.60
(-4.31%)
USD |
NASDAQ |
Dec 31, 16:00
36.10
+0.58
(+1.63%)
After-Hours: 20:00
Cogent Biosciences Cash from Investing (Quarterly): -155.05M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.43B |
| Ionis Pharmaceuticals, Inc. | 91.34M |
| Cidara Therapeutics, Inc. | -176.47M |
| Olema Pharmaceuticals, Inc. | 17.27M |
| ADMA Biologics, Inc. | -14.37M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -64.29M |
| Cash from Financing (Quarterly) | 217.37M |
| Free Cash Flow | -246.73M |
| Free Cash Flow Per Share (Quarterly) | -0.4678 |
| Free Cash Flow to Equity (Quarterly) | -64.25M |
| Free Cash Flow to Firm (Quarterly) | -62.89M |
| Free Cash Flow Yield | -5.84% |